Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force
Importance Effective prevention strategies for HIV infection are an important public health
priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or …
priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or …
[HTML][HTML] Use of a vaginal ring containing dapivirine for HIV-1 prevention in women
Background Antiretroviral medications that are used as prophylaxis can prevent acquisition
of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among …
of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among …
Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic …
MW Traeger, SE Schroeder, EJ Wright… - Clinical Infectious …, 2018 - academic.oup.com
Background Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is
effective in reducing HIV risk in men who have sex with men (MSM). However, concerns …
effective in reducing HIV risk in men who have sex with men (MSM). However, concerns …
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective …
Background HIV pre-exposure prophylaxis (PrEP) is highly effective in men who have sex
with men (MSM) at the individual level, but data on population-level impact are lacking. We …
with men (MSM) at the individual level, but data on population-level impact are lacking. We …
[HTML][HTML] Artificial intelligence and the implementation challenge
Background Applications of artificial intelligence (AI) in health care have garnered much
attention in recent years, but the implementation issues posed by AI have not been …
attention in recent years, but the implementation issues posed by AI have not been …
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys …
DH Barouch, FL Tomaka, F Wegmann, DJ Stieh… - The Lancet, 2018 - thelancet.com
Background More than 1· 8 million new cases of HIV-1 infection were diagnosed worldwide
in 2016. No licensed prophylactic HIV-1 vaccine exists. A major limitation to date has been …
in 2016. No licensed prophylactic HIV-1 vaccine exists. A major limitation to date has been …
Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment
While remdesivir has garnered much hope for its moderate anti-Covid-19 effects, its parent
nucleoside, GS-441524, has been overlooked. Pharmacokinetic analysis of remdesivir …
nucleoside, GS-441524, has been overlooked. Pharmacokinetic analysis of remdesivir …
Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis
Background Poor adherence to oral HIV pre-exposure prophylaxis (PrEP) diminishes its
clinical and public health benefits. This study synthesises evidence regarding …
clinical and public health benefits. This study synthesises evidence regarding …
[图书][B] Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
World Health Organization - 2016 - apps.who.int
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Consolidated Guidelines on HIV prevention, diagnosis, treatment and care for key populations …
Consolidated Guidelines on HIV prevention, diagnosis, treatment and care for key populations …
[HTML][HTML] Tenofovir-based preexposure prophylaxis for HIV infection among African women
Background Reproductive-age women need effective interventions to prevent the
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …